Clinical Hepatocellular Carcinoma

The molecular targets of interest have expanded from angiogenesis to cancer cell-directed oncogenic signaling pathways for advanced HCC treatment. The feasibility of combining locoregional therapies and targeted agents, and the use of novel agents after curative treatments are currently under active investigation. Finally, the therapeutic strategy has shifted from monotherapy to combination targeted therapy.

  • Partial Hepatectomy
  • Clinical Analysis of Cells
  • Intra - arterial Chemotherapy
  • AFP Blood Testing

Related Conference of Clinical Hepatocellular Carcinoma

August 03-04, 2026

21st Euro-Global Gastroenterology Conference

London, UK
September 07-08, 2026

26th International Conference on Gastroenterology and Hepatology

Edinburgh, Scotland
September 23-24, 2026

21th European Gastroenterology and Therapeutics Congress

Barcelona, Spain
September 29-30, 2026

7th Global Summit on Earth Science and Climate Change

Paris, France
June 24-25, 2027

15th World Gastro Summit

Paris, France

Clinical Hepatocellular Carcinoma Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in